{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T04:57:09Z","timestamp":1744693029121},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,12]]},"abstract":"<jats:p>Despite advances in estimating prognosis and predicting response to adjuvant systemic therapy, the status of the axillary lymph nodes remains a critical component in initial surgical planning and in determining therapeutic strategies for patients with breast cancer. Buoyed by evidence from multi-institutional randomized clinical trials, the last 2 decades have witnessed remarkable and practice-changing advances in our approach to the axilla. This review concentrates on the current best practice in axillary management for both node-negative and node-positive patients, with particular focus on the evolving management of the axilla in the era of neoadjuvant systemic therapy.<\/jats:p>","DOI":"10.1097\/grf.0000000000000232","type":"journal-article","created":{"date-parts":[[2016,9,23]],"date-time":"2016-09-23T09:37:16Z","timestamp":1474623436000},"page":"743-755","source":"Crossref","is-referenced-by-count":6,"title":["Current Management of the Axilla"],"prefix":"10.1097","volume":"59","author":[{"given":"DAMIAN","family":"McCARTAN","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MARY L.","family":"GEMIGNANI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230915","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1001\/jama.2011.90","article-title":"Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial","volume":"305","author":"Giuliano","year":"2011","journal-title":"JAMA"},{"key":"R2-20230915","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1007\/s10549-011-1665-1","article-title":"Sentinel lymph node biopsy compared with axillary lymph node dissection in early breast cancer: a meta-analysis","volume":"129","author":"Wang","year":"2011","journal-title":"Breast Cancer Res Treat"},{"key":"R3-20230915","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/S1470-2045(10)70207-2","article-title":"Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial","volume":"11","author":"Krag","year":"2010","journal-title":"Lancet Oncol"},{"key":"R4-20230915","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1001\/jama.2011.1034","article-title":"Association of occult metastases in sentinel lymph nodes and bone marrow with survival among women with early-stage invasive breast cancer","volume":"306","author":"Giuliano","year":"2011","journal-title":"JAMA"},{"key":"R5-20230915","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S1470-2045(13)70035-4","article-title":"Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial","volume":"14","author":"Galimberti","year":"2013","journal-title":"Lancet Oncol"},{"key":"R6-20230915","doi-asserted-by":"crossref","first-page":"3600","DOI":"10.1200\/JCO.2014.56.5838","article-title":"Radiation field design in the ACOSOG Z0011 (Alliance) trial","volume":"32","author":"Jagsi","year":"2014","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"R7-20230915","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/bjs.9673","article-title":"Meta-analysis of superficial versus deep injection of radioactive tracer and blue dye for lymphatic mapping and detection of sentinel lymph nodes in breast cancer","volume":"102","author":"Ahmed","year":"2015","journal-title":"Br J Surg"},{"key":"R8-20230915","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/S1470-2045(14)70460-7","article-title":"Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial","volume":"15","author":"Donker","year":"2014","journal-title":"Lancet Oncol"},{"key":"R9-20230915","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1056\/NEJMoa1415340","article-title":"Regional nodal irradiation in early-stage breast cancer","volume":"373","author":"Whelan","year":"2015","journal-title":"N Engl J Med"},{"key":"R10-20230915","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1200\/JCO.2009.23.7610","article-title":"Association between the 21-gene recurrence score assay and risk of locoregional recurrence in node-negative, estrogen receptor-positive breast cancer: results from NSABP B-14 and NSABP B-20","volume":"28","author":"Mamounas","year":"2010","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"R11-20230915","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1245\/s10434-013-3229-6","article-title":"Value of preoperative ultrasound-guided axillary lymph node biopsy for preventing completion axillary lymph node dissection in breast cancer: a systematic review and meta-analysis","volume":"21","author":"Diepstraten","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"R12-20230915","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jamcollsurg.2015.11.013","article-title":"Is preoperative axillary imaging beneficial in identifying clinically node-negative patients requiring axillary lymph node dissection?","volume":"222","author":"Pilewskie","year":"2016","journal-title":"J Am Coll Surg"},{"key":"R13-20230915","doi-asserted-by":"crossref","DOI":"10.1245\/s10434-016-5246-8","article-title":"How often does neoadjuvant chemotherapy avoid axillary dissection in patients with histologically confirmed nodal metastases? Results of a prospective study","author":"Mamtani","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"R14-20230915","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1245\/s10434-013-2992-8","article-title":"Sentinel lymph node biopsy after neoadjuvant chemotherapy in patients with cytologically proven node-positive breast cancer at diagnosis","volume":"20","author":"Park","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"R15-20230915","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.1002\/cncr.25152","article-title":"Cytologically proven axillary lymph node metastases are eradicated in patients receiving preoperative chemotherapy with concurrent trastuzumab for HER2-positive breast cancer","volume":"116","author":"Dominici","year":"2010","journal-title":"Cancer"},{"key":"R16-20230915","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1001\/jama.2013.278932","article-title":"Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial","volume":"310","author":"Boughey","year":"2013","journal-title":"JAMA"},{"key":"R17-20230915","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.clbc.2013.08.014","article-title":"Sentinel node biopsy after neoadjuvant chemotherapy in cytologically proven node-positive breast cancer","volume":"13","author":"Yagata","year":"2013","journal-title":"Clin Breast Cancer"},{"key":"R18-20230915","doi-asserted-by":"crossref","first-page":"2946","DOI":"10.1245\/s10434-007-9403-y","article-title":"Sentinel lymph node biopsy performed after neoadjuvant chemotherapy is accurate in patients with documented node-positive breast cancer at presentation","volume":"14","author":"Newman","year":"2007","journal-title":"Ann Surg Oncol"},{"key":"R19-20230915","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.clbc.2013.08.017","article-title":"Assessing the impact of neoadjuvant chemotherapy on the management of the breast and axilla in breast cancer","volume":"14","author":"McVeigh","year":"2014","journal-title":"Clin Breast Cancer"},{"key":"R20-20230915","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S1470-2045(13)70166-9","article-title":"Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study","volume":"14","author":"Kuehn","year":"2013","journal-title":"Lancet Oncol"},{"key":"R21-20230915","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1200\/JCO.2014.55.7827","article-title":"Sentinel node biopsy after neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer: the SN FNAC study","volume":"33","author":"Boileau","year":"2015","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"R22-20230915","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1200\/JCO.2015.64.0094","article-title":"Improved axillary evaluation following neoadjuvant therapy for patients with node-positive breast cancer using selective evaluation of clipped nodes: implementation of targeted axillary dissection","volume":"34","author":"Caudle","year":"2016","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"R23-20230915","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1093\/jnci\/djj158","article-title":"Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial","volume":"98","author":"Mansel","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"R24-20230915","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1245\/s10434-016-5104-8","article-title":"Optimal surgical management for occult breast carcinoma: a meta-analysis","volume":"23","author":"Macedo","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"R25-20230915","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1200\/JCO.2012.45.2615","article-title":"Lumpectomy plus tamoxifen with or without irradiation in women age 70 years or older with early breast cancer: long-term follow-up of CALGB 9343","volume":"31","author":"Hughes","year":"2013","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"}],"container-title":["Clinical Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00003081-201612000-00009","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T01:33:25Z","timestamp":1694741605000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00003081-201612000-00009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/grf.0000000000000232","relation":{},"ISSN":["0009-9201"],"issn-type":[{"value":"0009-9201","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]}}}